CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in APGE — Apogee Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in APGE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$58,886,726
+$23,477,754 QoQ
Shares Held
443,658
+5.5% QoQ
Ownership
0.586%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#34
of 285 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. APGE ranks #31 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in APGE
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,886,726 | 443,658 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $35,408,972 | 420,684 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $28,785,203 | 381,362 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,709,746 | 319,903 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $11,569,057 | 266,384 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $10,157,399 | 271,879 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $12,570,387 | 277,492 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $16,472,340 | 280,428 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $9,394,497 | 238,742 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $15,998,900 | 240,766 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $4,352,074 | 155,765 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,223,925 | 151,358 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||